An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder

American Journal of Psychiatry

Volumn 158, Issue 12, 2001, Pages 1989-1992

  Otto, M W ^a   Tuby, K S ^a   Gould, R A ^a   McLean, R Y S ^a   Pollack, M H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUVOXAMINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; HUMAN; META ANALYSIS; PANIC; PRIORITY JOURNAL; TREATMENT OUTCOME;

HUMANS; PANIC DISORDER; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0035185479     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.12.1989     Document Type: Article

References (29)

1. Practice guideline tor the treatment of patients with panic disorder
2. An algorithm-oriented treatment approach for panic disorder
3. Pharmacologic approaches to treatment-resistant panic disorder
4. A meta-analysis of treatment outcome for panic disorder
5. A rating scale for depression
6. Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin
7. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder
8. Effect of fluvoxamine on panic disorder
9. Paroxetine in the treatment of panic disorder: A randomised, double-blind, placebo-controlled study
10. Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia
11. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
12. The effect of citalopram in panic disorder
13. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
14. Sertraline in the treatment of panic disorder: A multi-site, double-blind, placebo-controlled, fixed-dose investigation
15. Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo
16. Sertraline in the treatment of panic disorder: A double-blind multicenter trial
17. Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial
18. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial
19. Publication bias: A problem in interpreting medical data
20. Publication bias in clinical research
21. Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
22. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta-analysis
23. Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates
24. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A metaanalysis
25. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine
26. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder
27. Empirically supported treatment for panic disorder: Costs, benefits, and stepped care
28. Meta analysis: Part 2: Assessing the quality of published meta-analyses